MTTs are composed of a strategic core structure, with academically defi ned individual scientifi c roles including those of a principal investigator, collaborating scientists from multiple disciplines, a project manager, and trainees. Th e strategic core may change over time as projects are initiated and concluded; these dynamic changes infl uence collaboration and performance within the team. MTTs were selected for CTSA support through an RFA mechanism that involves competitive peer review by a Scientifi c Review Committee, via a two-level review process, with the fi rst component focused on scientifi c impact and innovation of the proposed science (a translational research project involving human subjects). Th e second tier of peer review focused on team leadership, qualities of the principal investigator(s), involvement of trainees, and a team development plan. Th e CTSA embedded a team coach who regularly met with the MTT, and worked to improve the development plan in order to increase team eff ectiveness and capacity. MTTs selected for funding received a start-up pilot grant as well as access to CTSA-supported Key Resources, and focused their initial eff ort
Introduction
Th e case for teams in translational science Biomedical investigators are increasingly challenged to integrate insights from high-throughput "omics" research, focused hypothesis-driven basic research, and epidemiological studies to advance human health. Consequently, to understand larger biosocial health problems requires utilization of interdisciplinary research teams. 1 Major biomedical science advances are more oft en the result of multiinvestigator studies, and collaborative work has higher scientifi c impact and utility. 2, 3 Translational research has also increasingly adopted interdisciplinary approaches. Accordingly, there is considerable potential to apply knowledge from the nascent fi eld of the "Science of Team Science" to facilitate translational research within the Clinical and Translational Sciences Award (CTSA) framework. [4] [5] [6] Based on experience in other fi elds, it is reasonable to suggest that eff ective adoption of team approaches would accelerate translation of new discoveries into useful products and/or interventions. 7 Previously, we evaluated best practices from a systematic survey of 200 publications and proposed an academic-industry hybrid team model, the Multidisciplinary Translational Team (MTT) to generate new knowledge and deliverable products. 8 MTTs are a unique combination of several team types adapted for an academic environment with a dynamic core of scientists who interact on a common translational problem. Senior leadership provides domain-specific expertise, practical guidance, and modeling of interprofessional and leadership skills to trainees (project managers). MTTs require complementary activity of its participants, but not necessarily domain integration, which is a goal of transdisciplinarity. 8 Th e status of team science Team science presently incorporates multiinstitutional collaborations, 2,3 multidisciplinary approaches to complex research, 9 and training of scientists. 10 Because the fi eld is rapidly evolving, theoretical frameworks for studying the formation, evolution, and eff ectiveness of teams are in their infancy. [5] [6] [7] Th e eff ects of institutional context and interventions on translational research teams are also unclear. 6, 9 on conducting a specifi c collaborative translational project. Currently, 14 teams collaborate with the CTSA, involving 273 investigators (mean = 21 ± 9.8 members/MTT); of these, 59 are graduate/postgraduate students (mean = 4.9 ± 6 trainees/ MTT) and 54 are junior faculty trainees (mean = 4.1 ± 3 assistant professors/MTT). All CTSA-supported KL2 scholars participate in MTTs. At typical MTT meetings, total attendance ranged from 4-15 attendees.
General CTSA interventions
Th e CTSA provided several important infrastructure and team development interventions to all MTTs. Teams underwent an "onboarding" meeting at their initiation to orient the team to the CTSA, and to familiarize team members with the constructs of team science, operational considerations of the CTSA, and mutual expectations. Subsequently, the CTSA helped each team to produce a Team Development Planner, in which specifi c tasks and objectives related to team and individual (e.g., a Project Manager) development were articulated. We organized a weekly lecture series in translational science, and special monthly seminars in team science. To facilitate communication and interteam collaboration within the CTSA, the CTSA leadership also organized a Team Leadership Council (TLC), which functioned as a peer mentoring network. Th e TLC met monthly to share best practices in team leadership, and review team progress. CTSA leadership conducted periodic meetings with MTT leadership, and periodically attended MTT meetings and provided feedback. Th e CTSA also organized a team-building workshop, in which all MTTs participated. Other general support included a postdoctoral certifi cate in team science, a rich set of team science resources on our Web site, and ad hoc communications with CTSA leadership.
Measuring team performance
In an academic environment, an MTT may persist for years; thus, it is essential to measure how teams evolve, whether eff ective teams lead to increased scientifi c progress, and how institutional infrastructure can better promote productivity and innovation. To understand the evolution of MTTs, we generated mixed method assessments of the outcomes and team processes of MTTs using expert reviewers. 11 We studied a cohort of teams and developed a reproducible classifi cation from which to characterize the timedependent evolution of MTTs.
A fundamental limitation in studying team science is the lack of sophisticated and useful evaluation models, techniques, and methods. 5, 12 Due to the complexity of team science, most recognize the need to employ mixed methods approaches, 7, 13 including social network analysis, 14, 15 interviews and focus groups, 16, 17 as well as surveys. 12, 18 Evaluation methodology is informed by the outcomes important for specific team structures. In some cases, outcome evaluation (e.g., milestones and timelines) should predominate, but in other cases, process evaluation (e.g., team interaction, communication, and development) may be more important. 11 Hence, a key factor in evaluation is determining the components of team function that are most important to that team's scientifi c questions. 9, 19 A range of contextual (e.g., external environment, task design, group size), process (e.g., norms, cohesion, communication patterns), and cognition variables (e.g., mental models, effi cacy beliefs, and memory) infl uence eff ective team states (e.g., satisfaction, commitment) and outcomes (e.g., performance, publications, grants, turnover, etc.). [20] [21] [22] [23] We built upon a previous eff ort 11 and examined translational team longitudinal performance trajectories. There were three broad objectives of this study. First, we measured team performance (team processes and team outcomes) over time. Second, we identified team trajectory patterns, and used illustrative case information to understand context. Th ird, we developed recommendations for team assembly, management, and developmental interventions.
Methods

Overview of mixed method approach
Because interdisciplinary teams involve collaborations that change over time, blend diverse disciplines, 6 and involve boundaryspanning collaborations, 12, 24 assessment and evaluation are inherently complex. 7 Some consensus exists that mixed method approaches might best address these complexities, and allow for analyses that neither qualitative nor quantitative approaches could provide by themselves. 25, 26 Application of mixed methods involves thoughtful selection of design options, careful sampling practices, and a sophisticated process of data analysis and inference. 25, 27 Extending our previous eff orts, 8, 11 we employed an approach using various data sources: scored grant applications, milestone completion reports, citation indices, team meeting notes, Webbased surveys, observation scales, and team development planners. Outcome-based evaluation here refers to team-based goal accomplishment (e.g., milestones, publications, etc.), and process evaluation refers to team-based processes (e.g., leadership, collaboration, team development, etc.).
Team evaluation criteria
Using data from these measures and methods, we applied an existing team evaluation model. 11 Data from qualitative and quantitative sources above were reduced to produce a balanced panel of eight criteria ( Table 1 ) , including four process measures and four outcomes measures.
Data collection
Data from 10 diff erent MTTs were collected at two diff erent times during 2011 and 2013. Th ese teams were diverse in disease focus; research areas are summarized in Table 1 and were previously described. 11 Using eight criteria ( Table 1 ), expert panel members reviewed reports, data tables, publication statistics, narrative documents complied from interviews with team leaders, initial funding documents, scored grant applications, and annual reports. Each specifi c evaluative criterion (e.g., four research/scientifi c and four team development/maturation) was scored independently. For each team, expert panel members scored each of the eight criteria as 0 (not present), 1 (low), 2 (medium), or 3 (high). Each domain had four criteria so total scores ranged from 0 to 12 for each domain (i.e., 0-12 for research/scientifi c progress and 0-12 for team maturation/development).
Aft er panel members rated each team independently, the panel came together to reach a consensus rating on each criterion.
A consensus team rating on each criterion was achieved as follows:
(1) presentation of independent ratings, (2) explanation from each expert panel member supporting their initial rating, (3) discussion of diff erences in ratings, and (4) consensus reached for each criterion. Th is approach was modeled on the consensusbuilding approach used during scientifi c review panels for grant and contract applications.
Use of expert panels
Although imperfect, 28, 29 expert panels are oft en considered the best way to evaluate scientifi c endeavors, 30, 31 including grant application reviews and editorial boards. We used expert panels to balance objective data with contextual information to evaluate our MTTs. 32, 33 Evaluative judgment is a helpful addition to pure metrics in evaluating translational research. 34 Our panel consisted of fi ve members: the CTSA Principal Investigator, the Director and Assistant Director of Coordination for the CTSA, a Consulting Team Coach (team development expertise), and a Consulting Team Evaluator (business team performance evaluation expertise). Th e same methodology was employed for both evaluation periods.
Quantitative and qualitative analysis
Consensus ratings were analyzed and displayed using three methods: (1) bar graphs of the entire data set ( Figure 1 ), (2) sorted heatmaps to highlight the similarity and diff erences between the MTTs ( Figure 2 ) and to identify four MTT groups, and (3) radar plots of the eight evaluation criteria plotted on the same axes to demonstrate temporal diff erences between 2011 and 2013 ( Figure 3 ). We selected one team from each of the identifi ed groups as an exemplar, and developed a case study for each of those four teams.
Sorted heatmaps
We constructed three heatmaps, representing the consensus scores in 2011 ( Figure 2 A ), in 2013 ( Figure 2 B ), and the change from 2011 to 2013 (delta heatmap, Figure 2 C ). In each heatmap, rows represented the 10 MTTs, and the columns represented the eight process and outcome measures. Th e rows (MTTs) in the delta heatmap were then sorted in ascending order based on their total process and outcome scores, and the columns (outcomes) were sorted in ascending order based on their total scores across the MTTs. Th e resulting order of the rows and columns in the delta heatmap was subsequently used to reorder the rows and columns in the 2011 and 2013 heatmaps.
Case studies
The sorted heatmaps suggested four categories of MTT trajectories; we wished to understand the contextual details that might underlie these trajectories. Our qualitative examination was accomplished using notes (team observations, team coach notes, etc.) collected by the evaluation team. We selected one exemplar from each of the four categories and qualitatively examined its composition, dynamics, and interventions. Th ese insights led to generalizable recommendations for interventions best suited for the four diff erent team types.
Results
Heterogeneity in longitudinal patterns
We observed considerable heterogeneity in MTT trajectories ( Figure 1 ) for each of the four process variables (VC, TL, MM, EC) and four outcome variables (RP, RG, RC, PT). For example, MTT-5 had low scores overall across both years, MTT-8 had high scores overall across both years, and MTT-3 showed strong positive change. However, this display off ered little insight on commonalities and diff erences among the MTTs.
Categorization of teams and variables based on longitudinal patterns
Sorted heatmaps were generated to display patterns in the evaluation scores. Figures 2 A, B show the scores for each of the 10 MTTs in 2011 and 2013, respectively. scores (e.g., 2011 = 3, and 2013 = 3), both of which yield the same delta result but refl ect diff erent starting conditions. This overall method enabled us to analyze how the MTTs changed over time and how starting and ending scores infl uenced the trajectories. Th e "Total" score ( Figure 2 C ) ranged from +9 to -6. Th is range had three natural breaks, which were used to categorize the MTTs into four groups.
Th e fi rst group included three MTTs (MTT-1, MTT-2, MTT-3) that overall had large positive changes with no negative values. Th ese three MTTs began with low (0) to medium (2) starting scores in 2011 ( Figure 2 A ), and ended with several medium to high (3) scores in 2013 ( Figure 2 B ). Th ese three MTTs had strong positive changes in the four research outcome measures.
The second group (MTT-4, MTT-5, MTT-6) demonstrated a diff erent profi le, in which many of the consensus values either did not change (0) or decreased (-1) over time.
The third group (MTT-7, MTT-8, and MTT-9) had an overall decline or no change in total measures. Th ese three MTTs had many unchanged (0) and two high negative changes (-2). Th is assessment could indicate a low-functioning group, but review of Figures 2 A , B suggests that these MTTs were high-functioning groups, starting with maximum scores of 3 for many of the measures. Th erefore, even though these MTTs had medium (2) to high (3) scores in 2013, the diff erential change can be described as a ceiling eff ect. Collectively, the three MTTs in this group can be regarded as stable high-functioning groups over time.
Finally, the fourth group (MTT-10) had a strong overall negative score. Th is MTT had negative changes for all process scores and no change (0) for three of the four outcome measures. As shown in Figure 2 A , this MTT in fact started out with medium to high process scores, which fell over time resulting in a negative change score overall ( Figure 2 C ) .
MTTs appear to have had the most difficulty in improving "meeting management" and "transformative leadership" among the process variables and most success in improving "vision charter" ( Figure 2 C ) . In contrast, the MTTs had higher change in outcome variables, including a relatively high score (+9) for "progress across translational domains. "
Although the above sorted heatmap analysis suggested categorical groupings of MTT trajectories, it provided little causal explanation. We therefore analyzed an exemplar MTT from each group using a qualitative case study approach.
Case Studies of Exemplar Teams
MTT-2: Exemplar of large overall positive change in process and outcome scores with strong translational research progress
Team composition and dynamics MTT-2 is a "legacy MTT, " instantiated prior to the initiation of our CTSA. Th e team has a decades-long history of international leadership in the fi eld. Th e structure of the team was prototypical of academic teams of the 1980s and 1990s, namely, highly hierarchical, centralized decision making, leadership-based external collaborations, strong extramural funding, and exceptional publication productivity and impact. Th is MTT typifi es many academic research groups in structure and function.
Translational project
MTT-2 has focused on identifying predictors of mortality in severe trauma, and proposing and testing pharmacologic interventions to mitigate mortality. In 2011, their work spanned the T1 (preclinical) through T2 (observational clinical trials). In 2013, their work progressed from T2 to T3 (infl uencing medical practice) domains.
CTSA interventions
Th e CTSA provided substantive interventions in both process and infrastructure. In the area of process, we proposed a gradual migration of leadership to a junior faculty member who took the role of "Project Manager" in the team. Th e purpose of this intervention was to reduce the administrative burden on the senior leader by offl oading those tasks to the project manager, and to provide leadership succession planning. Th e project manager was funded by the CTSA as a KL2 scholar, and shouldered administrative tasks of meeting and agenda planning, meeting management, project management (milestones, timelines, and task accountability), and took a larger role in external communications (national meeting presentations, manuscript preparation, etc.).
In addition, the CTSA provided biostatistical support for the analysis of a large data set to understand the role of pathogenesis of injury responses. Th is analysis, coupled with additional systems biology insights from CTSA members, led to an innovative clinical trial. Other critical CTSA support included expertise to develop and implement a secure REDCap database for acquiring and managing an extensive data set, and editorial assistance for a grant application. Th e CTSA provided support from the Ethics Key Resource, which allowed the team to develop a comprehensive ethical framework in which to conduct clinical trials, and to develop better methods to increase participation and retention of clinical trial participants.
Process and outcomes
An important process goal was to develop a team structure that elicited and encouraged substantive contributions from all members. Accomplishing this goal entailed developing a shared vision and charter, a restructuring of team roles and dynamics, and increasing fl exibility on the part of team members to accept new roles and tasks. Th e objective outcomes of these interventions included a large federally funded clinical trial network, an expanded network of collaboration, both within and beyond Texas, and continued high grant and publication productivity for the team. Moreover, MTT-2 has initiated several multicenter clinical trials designed to reduce morbidity and mortality. Publication productivity for MTT-2 remained very strong (in part, related to the large size of the team), as did journal impact index, and average journal impact factor ( Table 2 ). As a consequence of the broader range of expertise in the team, the breadth of fi elds represented in team publications was also enlarged. Th is eff ect is and effi ciently managed. Disruptive interventions would be counterproductive to our overall goals of enhancing translational research. Hence, our approach was to use the resources of the CTSA, noted above, to provide incentives to applying team science approaches to the clinical problem of interest to them. Moreover, as additional success accrued to the team members as a consequence of incorporating the changes, subtle but important cultural shift s occurred within the team, reinforcing the productivity of the team.
Th is case exemplifi es the prototypical productive academic research group and shares commonalities with other MTTs in that group (MTT-1, MTT-2, MTT-3). Th e lessons and insights gained from this MTT are likely generalizable to similar teams at other institutions. Th e traditional reward structure recognizes, supports, and encourages a traditional leadership style, and devalues teamwork. Th ese observations include the critical importance of articulating team science benefi ts, providing tangible support, and incorporating team science values and processes as part of the ongoing workgroup productivity, rather than imposing an entirely new structure on an existing group.
MTT-5: Exemplar of marginal overall positive change in process and outcome scores, with good translational progress
Team composition and dynamics MTT-5 was initiated in our fi rst round of MTT funding (second year of the CTSA) as a "new team" and demonstrated considerable diff erences from MTT-2. Th e expertise of MTT-5 was highly focused on basic sciences and scientific technology, assay development, and the protein structures that underlie a predictive biomarker. Th e MTT however, did not have a clinical scientist with expertise and ongoing clinical interest in the disease area of focus, nor a pool of well-characterized patients. Consequently, MTT-5 had limited access to human clinical samples from patients with that disease, and no clinical trial coordinators to operationalize enrollment and sample collection. Finally, despite considerable basic science expertise, there was minimal experience on the team to lead an interdisciplinary project.
Translational project
MTT-5 work had interest in viral carcinogenesis and sought to identify biomarkers that associate with the transition from benign to malignant disease. By 2013, the MTT had established a proteomic marker, developed a clinical assay for its validation, and had added an independent nucleic marker to the panel. Th e scope of science of MTT-5 was largely in T1. Table 1 . Data from 2011 are shown in yellow and data from 2013 are shown in purple. Areas of overlap, which represent outcomes that have been maintained or improved in 2013 versus 2011, are shown in magenta. seen not simply as a result of several disciplines being included in the team, but by real collaborative publications with authors from diff erent disciplines on each publication. Over half (27 of 50) of the postintervention publications by MTT-2 were in new/ diff erent scientifi c categories ( Table 3 ). Balanced growth across all measured parameters over time, in both team process and team outcomes, is illustrated in Figure 3 A .
Period Baseline 3 years Postintervention 3 years
Insights about team type and appropriate interventions
Th e CTSA interventions were not without risk. Th e legacy MTT-2 was well-funded, highly productive, internationally known,
CTSA interventions
Th e purpose of the CTSA interventions was to ensure that MTT-5 had suffi cient expertise to accomplish the goal of predictive biomarker development. Necessary expertise included a physician with expertise in the disease and organ system of interest, and a clinical coordinator who could manage day-to-day project tasks of subject recruitment and sample collection. Th e Novel Methodologies Key Resource provided access to mass spectrometerbased selective reaction monitoring (SRM) techniques that accelerated the analysis of proteins of interest in biospecimens. Biostatistics expertise was inserted into the team to facilitate interim and fi nal analyses and to improve experimental design. Process interventions included training of a project manager in business practices, meeting management (agendas, minutes, Web-based meeting management repository), establishing team consensus on milestones, timelines, and procedural obstacles.
Process and outcomes
Th e incorporation of the expertise of a clinician-investigator accelerated the identifi cation of patients who might be recruited as research subjects. Th at expertise also informed discussion about the ultimate utility of the developmental biomarker. Th e CTSA provided a clinical trial coordinator to the team, whose responsibility was to attend various geographically dispersed clinics, and enroll identifi ed patients into the trial. Sample collection, indexing, preliminary processing, and biobanking were also facilitated by the coordinator. Th e team has developed a candidate biomarker panel which, if validated, would signifi cantly impact the practice of medicine in this fi eld. Th is example of basic science impacting clinical medicine and decision making is a prototype of translational medicine. Th e strong basic science performance in assay development was complemented by clinical knowledge and accelerated sample acquisition. Although the process measures have not yet improved, the measurable progress in sample acquisition, sample analysis, and biostatistical insights demonstrate translational progress. Publication productivity rose from 6 to 15 publications, the publication impact index rose from 34 to 49 ( Table 2 ) , and the team published in new areas of science and new journals ( Table 3 ). Collectively, the intervention of the CTSA has led to measurable acceleration of translational science. MTT-5 team growth was observed in all measured parameters, in a balanced fashion, with the initial starting points approximating zero prior to team initiation, and expanding in 2013 ( Figure 3 B ).
Insights about team type and appropriate interventions
A key limitation of MTT-5 was the lack of clinical and clinical research expertise. In translational science, the perspective of clinical medicine must always be present, if not always in the forefront. Th is expertise is necessary for intellectual, conceptual, and practical reasons. Clinical expertise helps to frame questions and concepts properly, so that the most important questions are addressed in the most impactful manner. Clinical expertise is also required for facile access to human specimens. Advances in basic science and technology clearly can impact the diagnosis and management of clinical disorders. Teams early in translation (basic science-rich) should be encouraged to include clinical researchers in order to minimize obstacles that will otherwise likely be encountered later in the translational pathway, and clinical teams should be encouraged to include strong basic science members to ensure that the best science and technology are applied to the clinical question.
MTT-9: Exemplar of stable high-functioning team with few changes in process and outcome
Team composition and dynamics MTT-9 was initiated coincident with funding of our CTSA program, and thus was an "initial team. " Individually, its members had signifi cant productivity and participated in two national disease networks. The formalization of this team presaged the MTT concept, a foundation of our CTSA program. We postulated that by incorporating the expertise of other disciplines, we could augment the productivity of the national disease networks. Accordingly, systems biology, proteomics, biostatistics, and bioinformatics were formally incorporated into the team. Th is team intentionally used senior specialty trainees in the role of project manager to provide leadership training. Advantages of this approach included: (1) the ability of trainees, with fewer confl icting responsibilities, to manage the logistical requirements of the team, (2) the acquisition of business skills (e.g., meeting and agenda management) and interpersonal skills (e.g., confl ict management) by trainees, and (3) an opportunity for the trainee to have a formalized role in determining scientifi c directions. However, there were important limitations of this approach. Periodic change in the project manager due to completion of training resulted in disruption of the continuity of project fl ow. In addition, some trainees initially had insuffi ciently well-developed skill sets to manage eff ectively a multidisciplinary group of high-performing, highly motivated faculty.
Translational project
Th e team used cytokine expression from an organ-specifi c biofl uid obtained both locally and from the national networks, to develop a quantitative method for producing a molecular phenotype of subjects with mild to severe expression of the disease of interest, using existing standardized biostatistical tools and approaches. Th e scope of MTT-9 was largely in T1 and T2. Publication by source title   Team  Baseline  Postintervention New categories  Baseline  Postintervention New categories   Team 2  49  50  27  50  50  27   Team 5  3  3  2  6  3  3   Team 9  5  9  5  17  30  11   Team 10  7  6  1  7  5  4   Table 3 . Changes in Web of Science published source titles and scientifi c categories by exemplar team.
Publication by scientifi c category
CTSA interventions
Standard analytical methodologies for complex diseases are largely descriptive and do not inform understanding of the mechanisms underlying disease heterogeneity. To address that concern, the CTSA introduced a new team member with strong expertise in novel visual analytic methods. The purpose of the intervention was to draw additional mechanistic insights about heterogeneity from the existing data sets. Using bipartite networks, MTT-9 identifi ed several spatial clusters of cytokine expression that mapped to patient clusters of varying disease severity, and suggested that activation of a specifi c pathway was causally linked to severe disease. Th ese insights provided a possible mechanism-based disease classifi cation. Th e CTSA also provided important infrastructural support via the Webbased information sharing portal iSpace for vision and charter documents, agendas, protocols, and minutes.
Process and outcomes
Th is team had strong publication productivity with high-impact manuscripts, novel publication venues, and high interdisciplinarity, but faced a temporary shortfall in extramural funding, which constrained the scope of projects conducted during that time period. Because the team members had been quite productive prior to the instantiation of the MTT, team metrics demonstrate a ceiling eff ect. Nevertheless, publications were strong both before and aft er CTSA intervention; the publication impact index rose from 156 to 268 ( Table 2 ) , and an impressive change in diff erent publications in diff erent scientifi c categories and publication outlets was seen ( Table 3 ) . Th e negative change in process measures may have resulted from the rapid turnover among project managers. Th ese observations of relatively stable high functioning are depicted in Figure 3 C .
Insights about team type and appropriate interventions
MTT-9 chose to use relatively junior team members in the role of project manager. In our MTT model, the project manager serves a role similar to a chief operating offi cer, with responsibility for managing day-to-day project fl ow, scheduling, logistics, timelines, and deliverables, and for helping to create a culture of accountability. Th is approach must necessarily incorporate a formalized plan for leadership succession, as trainees have a limited time at their training institution, and potentially disruptive transitions will occur. More generally, teams with established investigators members may face similar challenges if a key leader moves to another institution. Many, but not all, trainees have the necessary skills (or can quickly acquire them with appropriate mentorship) to fl ourish in this role. Careful vetting of potential project managers is critical to ongoing team success and productivity, and individualized mentoring focused on acquisition of specifi c skills can mitigate limitations.
MTT-10: Exemplar of strong overall negative change in process and outcome, but with translational progress
Team composition and dynamics MTT-10 was funded by a pilot MTT award near the middle of our CTSA funding cycle, and hence is a "new team. " It comprised three senior investigators, two of whom had a sustained record of extramural funding. Th e area of study had important implications for both biology and public policy. This team began in the style and structure of a collaborative work group, rather than a multidisciplinary team, in that low scores were recorded for team process measures such as empowered leadership, shared vision, etc. (see Figure 3 D ). Communications among team members were judged to be less than optimal, and the project management, communication, and business management skill set of the initial project manager did not align with the needs of the team. Ultimately, a new project manager emerged.
Translational project
MTT-10 explored the novel hypothesis that in utero exposures could result in fetal reprogramming that would lead to expression of disease in children and ultimately in adults. Th e scope of projects undertaken by MTT-10 was in the T1 domain.
CTSA interventions
CTSA interventions for this team included the initial infusion of funds to support team development and scientifi c project work and editorial assistance for preparation of manuscripts and grant applications.
Process and outcomes
Th e team developed a proposal for a small federal grant which was successfully submitted, and later funded. However, objective research productivity fell both in terms of number of publications (15 to 9) and publication impact index (92 to 54), but the average journal impact factor remained stable at about 6 ( Table 2 ). Few new scientifi c areas or publication titles were seen ( Table 3 ). Contraction of the performance plot ( Figure 3 D ) is seen from 2011 to 2013.
Insights about team type and appropriate interventions
An important lesson from analysis of this team's trajectory is that careful vetting of the team leadership skills of the project manager is critically important to ongoing team success. Th is observation was also made in MTT-1, an initial team. Hence in two teams, quite diff erent in vision, composition, and scope, the same observation about the critical need for skills assessment in the leadership team can be made. It is important to note that the deterioration in team function was recognized and CTSA interventions included team coaching sessions, leadership meetings, and TLC interactions.
Discussion and Implications
Summary of fi ndings and interventions for four team type trajectories
On the basis of expert panel evaluations, we observed four discrete team trajectories. Understanding team trajectories may enable CTSA investigators to provide needed leadership, resources, and proactive guidance through team interventions, to maximize the potential of multidisciplinary teams. We highlight four team types as prototypes: (1) teams with traditional leadership, (2) teams focused on basic science, (3) stable high-functioning teams with junior project managers, and (4) teams with inexperienced leaders.
Teams with traditional leadership
Th is team type is a traditional academic research group in which productive and thoughtful leaders can embrace team science principles, resulting in rapid novel and productive research outcomes. As exemplifi ed by MTT-2, many academic research teams have a structure dominated by the Principal Investigator; within that structure, two or more relatively independent project groups may report to the PI. Because the culture of research productivity is already in place, CTSA eff orts can be directed toward development of team science by providing incentives for team process development and by properly attributing the successes of the team to team members not just the team leader. Th e balanced growth in nearly all process and outcome measures seen in MTT-2 (see Figure 3 A ) is exemplary.
Teams focused on basic science
Th is team type is illustrated by basic science groups that study specifi c diseases and can benefi t from the added perspective and advice of clinically trained team members to convey the signifi cance and health-relatedness of the research. Translational progress will be impaired by the lack of such expertise, as exemplifi ed in MTT-5. Accordingly, the CTSA intervention can be the provision of necessary expertise to the team to accelerate translation.
Stable high-functioning teams with junior project managers
Many benefi ts accrue to teams with actively engaged Project Managers who can focus much of their professional time on the goals of the team. Th is team type and our experience in the development of project managers is chronicled elsewhere. 35 Project Managers, particularly early in their career, benefi t from leadership development, acquisition of business skills, positive role modeling, and management training that would otherwise not be formally provided. However, the more junior team members may also have the highest rate of transition to other stages of training, resulting in team disruption, as in MTT-9. Careful vetting of prospective Project Managers and informed planning for leadership succession can help to mitigate costly disruptions.
Teams with inexperienced leaders
Th is team type is a prototype of nascent teams with a more junior PI. Here, leadership, both scientifi c and interpersonal, is a key element of team dynamics and a requirement for optimal team function. Both of these aspects of leadership are necessary for team success. Early assessment of the scientifi c and interpersonal leadership of team leaders and project managers, coupled with appropriate mitigation strategies, can prevent failures in team process and outcome.
CTSA impact on MTT productivity and innovation
In this analysis, we refer to the term "innovation" as the process of applying a novel idea or method to a new research domain, with specifi c actions and outcomes. We used changes (3 years before and aft er CTSA intervention) in Web of Science published sources (journal) titles and discrete scientific categories as indicators of MTT innovation. Our evaluation indicates that MTTs with eff ective team processes develop interdisciplinary concepts and publications that would not, and perhaps could not, occur without the interaction among team members, and have signifi cantly greater impact and reach as indicated by team bibliometrics and a broader range of journals and scientifi c fi elds in which team publications occur. Th e consensus scores also suggested a positive correlation between the four process and four outcome scores. We interpreted these fi ndings to indicate that CTSAs have positive impact on both scientifi c productivity and innovation in MTTs.
Recommendations for interventions to accelerate translational team innovation
A relatively sparse literature exists to guide the development, assessment, and interventions of translational teams. 36 Although general guidance for developing team science competencies is available, 37 our identifi cation of several team types suggests that a single approach may not be appropriate for all teams, and that characteristics of the team can inform appropriate interventions. Our CTSA provided interventions in both proactive and reactive modes. When potential problems, or opportunities for improvement, are prospectively identifi ed in MTTs, the intervention can be proactive. However, we believe that the CTSA leadership must also be closely connected to its MTTs, in order to recognize new problems quickly, and to provide reactive interventions to mitigate unforeseen problems.
We noted that one process measure, Transformative Leadership, generally did not change from year to year. One inference to be drawn from this observation is that leadership is diffi cult to defi ne and more diffi cult to change substantively. From a programmatic perspective, we propose fi ve types of interventions that are applicable to translational teams ( Table 4 ) and can be applied either proactively, or reactively, as determined by the needs of the team. A testable hypothesis is that such interventions will produce balanced growth in translational teams as depicted in Figure 3 A .
Future research and team trajectory evaluation
Th ere are three distinct areas of research critical to optimization of translational teams. First, the use of expert panels to evaluate both process and outcome measures has strengths and limitations that require better defi nition.
Second, improved delineation of the characteristics of transformational leadership skills among scientific team leaders is needed. This study suggests that leader-specific criteria (e.g., meeting management and transformational leader behavior) were the most resistant to change. Acquisition of complex leadership skills, including transformational behavior, is a function of personality, 48 and context of development, 49 and requires longitudinal interventions with appropriate timing. 50 Thus, how best to foster transformational leadership skills in research settings is a significant area for future inquiry.
Th ird, replication of our fi ndings of team types would be useful to understand the robustness of the observations and support their generalizability. We view these four team types as having common features present both within our institution, and in other academic health centers, but additional observations are necessary to confi rm that suggestion. It is possible that the four team types we observed are situation-specifi c or culture-based. Th e types of interventions most helpful to each team type must be determined and validated. Only when such team trajectories can be diagnosed and addressed, will maximal productivity, societal impact, and accelerated innovations produced from MTTs be most fully achieved.
